References
- Aminian A, Kermansaravi M, Azizi S, et al. Bariatric surgical practice during the initial phase of COVID-19 outbreak. Obes Surg. 2020;30(9):3624–3627.
- Haryalchi K, Heidarzadeh A, Abedinzade M, et al. The importance of happy hypoxemia in COVID-19. Anesth Pain Med. 2021;11(1):e111872.
- Montalvan V, Lee J, Bueso T, et al. Neurological manifestations of COVID-19 and other coronavirus infections: a systematic review. Clin Neurol Neurosurg. 2020;194:105921.
- Manto M, Dupre N, Hadjivassiliou M, et al. Medical and paramedical care of patients with cerebellar ataxia during the COVID-19 outbreak: seven practical recommendations of the COVID 19. Front Neurol. 2020;11:516.
- Mobayen M, Yousefi S, Mousavi M, et al. The presentation of spontaneous splenic rupture in a COVID-19 patient: a case report. BMC Surg. 2020;20(1):220.
- Cheng Q, Yang Y, Gao J. Infectivity of human coronavirus in the brain. EBioMedicine. 2020;56:102799.
- Saleki K, Banazadeh M, Saghazadeh A, et al. The involvement of the Central nervous system in patients with COVID-19. Rev Neurosci. 2020;31(4):453–456.
- Saleki K, Banazadeh M, Miri NS, et al. Triangle of cytokine storm, Central nervous system involvement, and viral infection in COVID-19: the role of sFasL and neuropilin-1. Rev Neurosci. 2022;33(2):147–160.
- Ranjbar H, Soti M, Banazadeh M, et al. Addiction and the cerebellum with a focus on actions of opioid receptors. Neurosci Biobehav Rev. 2021;131:229–247.
- Miquel M, Vazquez-Sanroman D, Carbo-Gas M, et al. Have we been ignoring the elephant in the room? Seven arguments for considering the cerebellum as part of addiction circuitry. Neurosci Biobehav Rev. 2016;60:1–11.
- D'Angelo E. Chapter 6 - Physiology of the cerebellum. In: Manto M, Huisman TAGM, editors. Handbook of clinical neurology. Vol. 154. Amsterdam, The Netherlands: Elsevier; 2018. p. 85–108.
- World Health Organization. Coronavirus disease 2019 (COVID-19): situation report, 73. Geneva: World Health Organization; 2020.
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054–1062.
- Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–481.
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA 2020;323(13):1239–1242.
- Guan WJ, Ni ZY, Hu Y, China Medical Treatment Expert Group for Covid-19, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
- Grasselli G, Zangrillo A, Zanella A, COVID-19 Lombardy ICU Network, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the lombardy region Italy. JAMA 2020;323(16):1574–1581.
- Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in lombardy, Italy: early experience and forecast during an emergency response. JAMA 2020;323(16):1545–1546.
- Covino M, De Matteis G, Santoro M, et al. Clinical characteristics and prognostic factors in COVID-19 patients aged ≥80 years. Geriatr Gerontol Int. 2020;20(7):704–708.
- Ciceri F, Castagna A, Rovere-Querini P, et al. Early predictors of clinical outcomes of COVID-19 outbreak in milan, Italy. Clin Immunol. 2020;217:108509.
- Page JH, Londhe AA, Brooks C, et al. Trends in characteristics and outcomes among US adults hospitalised with COVID-19 throughout 2020: an observational cohort study. BMJ Open. 2022;12(2):e055137.
- Marik PE, Iglesias J, Varon J, et al. A scoping review of the pathophysiology of COVID-19. Int J Immunopathol Pharmacol. 2021;35:20587384211048026.
- Farias LPG, Fonseca E, Strabelli DG, et al. Imaging findings in COVID-19 pneumonia. Clinics (Sao Paulo). 2020;75:e2027.
- Morand A, Campion JY, Lepine A, et al. Similar patterns of [(18)F]-FDG brain PET hypometabolism in paediatric and adult patients with long COVID: a paediatric case series. Eur J Nucl Med Mol Imaging. 2022;49(3):913–920.
- Fontana IC, Souza DG, Pellerin L, et al. About the source and consequences of (18)F-FDG brain PET hypometabolism in short and long COVID-19. Eur J Nucl Med Mol Imaging. 2021;48(9):2674–2675.
- Guedj E, Campion JY, Dudouet P, et al. (18)F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. 2021;48(9):2823–2833.
- Delorme C, Paccoud O, Kas A, CoCo-Neurosciences study group and COVID SMIT PSL study group, et al. COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings. Eur J Neurol. 2020;27(12):2651–2657.
- Siripongsatian D, Kunawudhi A, Promteangtrong C, et al. Alterations in 18F-FDG PET/MRI and 15O-Water PET brain findings in patients with neurological symptoms after COVID-19 vaccination: a pilot study. Clin Nucl Med. 2022;47(3):e230–e239.
- Martini AL, Carli G, Kiferle L, et al. Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients. Eur J Nucl Med Mol Imaging. 2022;1–13.
- Verger A, Kas A, Dudouet P, et al. Visual interpretation of brain hypometabolism related to neurological long COVID: a French multicentric experience. Eur J Nucl Med Mol Imaging. 2022;49(9):3197–3202.
- Guedj E, Million M, Dudouet P, et al. 18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders? Eur J Nucl Med Mol Imaging. 2021;48(2):592–595.
- Meo SA, Abukhalaf AA, Alomar AA, et al. Magnetic resonance imaging (MRI) and neurological manifestations in SARS-CoV-2 patients. Eur Rev Med Pharmacol Sci. 2021;25(2):1101–1108.
- Beyrouti R, Adams ME, Benjamin L, et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020;91(8):889–891.
- Möhn N, Saker F, Bonda V, et al. Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse. J Neurol. 2020;267(10):2803–2805.
- Chia KX, Polakhare S, Bruno SD. Possible affective cognitive cerebellar syndrome in a young patient with COVID-19 CNS vasculopathy and stroke. BMJ Case Rep. 2020;13(10):e237926.
- Franceschi AM, Arora R, Wilson R, et al. Neurovascular complications in COVID-19 infection: case series. AJNR Am J Neuroradiol. 2020;41(9):1632–1640.
- Parsons N, Outsikas A, Parish A, et al. Modelling the anatomic distribution of neurologic events in patients with COVID-19: a systematic review of MRI findings. AJNR Am J Neuroradiol. 2021;42(7):1190–1195.
- Freeman CW, Masur J, Hassankhani A, et al. Coronavirus disease (COVID-19)-related disseminated leukoencephalopathy: a retrospective study of findings on brain MRI. AJR Am J Roentgenol. 2021;216(4):1046–1047.
- Chen R, Wang K, Yu J, et al. The spatial and Cell-Type distribution of SARS-CoV-2 receptor ACE2 in the human and mouse brains. Front Neurol. 2020;11:573095.
- Meinhardt J, Radke J, Dittmayer C, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of Central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24(2):168–175.
- Rastogi A, Bingeliene A, Strafella AP, et al. Reversible neurological and brain MRI changes following COVID-19 vaccination: a case report. J Neuroradiol. 2022;S0150-9861(22)00107-9.
- Shah P, Patel J, Soror NN, et al. Encephalopathy in COVID-19 patients. Cureus 2021;13(7):e16620.
- Ciolac D, Crivorucica I, Zota E, et al. Extensive cerebellar involvement and cognitive impairment in COVID-19-associated acute necrotizing encephalopathy. Ther Adv Neurol Disord. 2021;14:1756286420985175.
- Ebrahimpour S, Mohseni Afshar Z, Mohseni S, et al. Neurologic manifestations in patients with COVID-19: a case report. Caspian J Intern Med. 2020;11(Suppl 1):557–560.
- Sartoretti E, Sartoretti T, Imoberdorf R, et al. Long-segment arterial cerebral vessel thrombosis after mild COVID-19. BMJ Case Rep. 2020;13(9):e236571.
- Demir G, Balaban O, Tekeci MH, et al. Fahr’s syndrome presenting with seizures in SARS-CoV-2 (COVID-19) pneumonia-a case report. Neurol Sci. 2020;41(11):3063–3065.
- Ata F, Yousaf Q, Veliyankodan Parambil J, et al. A 28-year-old man from India with SARS-Cov-2 and pulmonary tuberculosis co-infection with central nervous system involvement. Am J Case Rep. 2020;21:e926034.
- Watanabe M, Takahashi Y, Tanaka K, et al. Autoimmune acute myelitis with Guillain-Barré syndrome and cerebellar ataxia after COVID-19 infection: a case report [conference abstract]. Neurology. 2022;98(18 SUPPL).
- Morgun AV, Salmin VV, Boytsova EB, et al. Molecular mechanisms of Proteins - Targets for SARS-CoV-2 (review). Sovrem Tekhnologii Med. 2021;12(6):98–108.
- Siddiqui R, Mungroo MR, Khan NA. SARS-CoV-2 invasion of the Central nervous: a brief review. Hosp Pract (1995). 2021;49(3):157–163.
- Matschke J, Lütgehetmann M, Hagel C, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919–929.
- Colombo D, Falasca L, Marchioni L, et al. Neuropathology and inflammatory cell characterization in 10 autoptic COVID-19 brains. Cells. 2021;10(9):2262.
- Fadakar N, Ghaemmaghami S, Masoompour SM, et al. A first case of acute cerebellitis associated with coronavirus disease (COVID-19): a case report and literature review. Cerebellum. 2020;19(6):911–914.
- Abdel-Mannan O, Eyre M, Löbel U, et al. Neurologic and radiographic findings associated with COVID-19 infection in children. JAMA Neurol. 2020;77(11):1440–1445.
- Rodriguez-Quiroga S, Aldecoa M, Morera N, et al. Ataxia myoclonus syndrome in mild acute COVID-19 infection. Cerebellum. 2022;17:1–3.
- Zimmermann KM, Harmel J, Wojtecki L. CORE-Myoclonus syndrome: a proposed neurological initial manifestation of COVID-19. Mov Disord Clin Pract. 2021;8(4):637–638.
- Heneka MT, Golenbock D, Latz E, et al. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther. 2020;12(1):69.
- Schellekens MMI, Bleeker-Rovers CP, Keurlings PAJ, et al. Reversible Myoclonus-Ataxia as a postinfectious manifestation of COVID-19. Mov Disord Clin Pract. 2020;7(8):977–979.
- Ishaq H, Durrani T, Umar Z, et al. Post-COVID opsoclonus myoclonus syndrome: a case report from Pakistan. Front Neurol. 2021;12:672524.
- Werner J, Reichen I, Huber M, et al. Subacute cerebellar ataxia following respiratory symptoms of COVID-19: a case report. BMC Infect Dis. 2021;21(1):298.
- Grimaldi S, Lagarde S, Harlé JR, et al. Autoimmune encephalitis concomitant with SARS-CoV-2 infection: insight from (18)F-FDG PET imaging and neuronal autoantibodies. J Nucl Med. 2020;61(12):1726–1729.
- Malik P, Patel K, Akrmah M, et al. COVID-19: a disease with a potpourri of histopathologic findings-a literature review and comparison to the closely related SARS and MERS. SN Compr Clin Med. 2021;3(12):2407–2434.
- Solomon IH, Normandin E, Bhattacharyya S, et al. Neuropathological features of COVID-19. N Engl J Med. 2020;383(10):989–992.
- Reichard RR, Kashani KB, Boire NA, et al. Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology. Acta Neuropathol. 2020;140(1):1–6.
- Paniz-Mondolfi A, Bryce C, Grimes Z, et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol. 2020;92(7):699–702.
- Bryce C, Grimes Z, Pujadas E, et al. Pathophysiology of SARS-CoV-2: targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response. The Mount Sinai COVID-19 autopsy experience. MedRxiv. 2020.
- Bradley BT, Maioli H, Johnston R, et al. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington state: a case series. Lancet 2020;396(10247):320–332.
- Janjua T, Moscote-Salazar LR. Acute cerebellar strokes with anoxic brain injury after a cardiopulmonary arrest in SARS-CoV-2 patient. Acta Med Indones. 2020;52(2):177–178.
- Lou JJ, Movassaghi M, Gordy D, et al. Neuropathology of COVID-19 (neuro-COVID): clinicopathological update. Free Neuropathology. 2021;2:2.
- Aasfara J, Jidane S, Laarje A, et al. SARS-CoV-2, recurrent ischemic strokes and carotid macrothrombosis: the other face of the cytokine storm (a case report). Pan Afr Med J. 2021;38:34.
- Mishra S, Choueka M, Wang Q, et al. Intracranial hemorrhage in COVID-19 patients. J Stroke Cerebrovasc Dis. 2021;30(4):105603.
- Al-Dalahmah O, Thakur KT, Nordvig AS, et al. Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage. Acta Neuropathol Commun. 2020;8(1):147.
- Kirschenbaum D, Imbach LL, Rushing EJ, et al. Intracerebral endotheliitis and microbleeds are neuropathological features of COVID-19. Neuropathol Appl Neurobiol. 2021;47(3):454–459.
- Fanou EM, Coutinho JM, Shannon P, et al. Critical Illness-Associated cerebral microbleeds. Stroke. 2017;48(4):1085–1087.
- Lancella L, Esposito S, Galli ML, et al. Acute cerebellitis in children: an eleven year retrospective multicentric study in Italy. Ital J Pediatr. 2017;43(1):54. 12
- Nussinovitch M, Prais D, Volovitz B, et al. Post-infectious acute cerebellar ataxia in children. Clin Pediatr (Phila). 2003;42(7):581–584.
- Van Samkar A, Poulsen MNF, Bienfait HP, et al. Acute cerebellitis in adults: a case report and review of the literature. BMC Res Notes. 2017;10(1):610.
- Bozzola E, Bozzola M, Tozzi AE, et al. Acute cerebellitis in varicella: a ten year case series and systematic review of the literature. Ital J Pediatr. 2014;40:57.
- Moreno-Escobar MC, Feizi P, Podury S, et al. Acute cerebellitis following SARS-CoV-2 infection: a case report and review of the literature. J Med Virol. 2021;93(12):6818–6821.
- Emekli AS, Parlak A, Göcen NY, et al. Anti-GAD associated post-infectious cerebellitis after COVID-19 infection. Neurol Sci. 2021;42(10):3995–4002.
- Llorente Ayuso L, Torres Rubio P, Beijinho do Rosário RF, et al. Bickerstaff encephalitis after COVID-19. J Neurol. 2021;268(6):2035–2037.
- de Lorenzo Alvarez A, Revilla Á, Corbalán T, et al. Ischemic stroke and purpuric dermatitis as COVID-19-related complications in a peritoneal dialysis patient. CEN Case Rep. 2021;10(2):250–254.
- Oosthuizen K, Steyn EC, Tucker L, et al. SARS-CoV-2 encephalitis presenting as a clinical cerebellar syndrome. A Case Report. 2021;97(1):27–29.
- Liaw N, Liebeskind DS. COVID-19 era stroke service: virtually normal. Curr Treat Options Neurol. 2020;22(11):39.
- Patel HN, Syed A, Lobel JS, et al. Cerebellar infarction requiring surgical decompression in patient with COVID 19 pathological analysis and brief review. Interdiscip Neurosurg. 2020;22:100850.
- Quenzer F, Smyres C, Tabarez N, et al. Large cerebellar stroke in a young COVID-19-Positive patient: case report. J Emerg Med. 2021;61(1):29–36.
- Roshkovan L, Thompson JC, Chatterjee N, et al. A 53-Year-Old man presents to the ED with shortness of breath, cough, and fever [article]. Chest. 2021;159(2):e107–e113.
- Tomar LR, Shah DJ, Agarwal U, et al. Acute Post-Infectious cerebellar ataxia due to COVID-19. Mov Disord Clin Pract. 2021;8(4):610–612.